Evidence quality is an effectiveness outcome in its own right. This guide covers exactly what FSA examiners request, the most common evidence gaps, and how compliance infrastructure directly determines examination readiness.
Japan's National AML/CTF Action Plan for 2024–2026 directly shapes FSA supervisory priorities through the FATF 2028 evaluation period. This guide explains its implications for mid-market financial institutions.
FATF's effectiveness assessment measures real outcomes, not framework existence. Japan's 2021 evaluation identified specific mid-market institution gaps that the 5th Round will reassess directly.
Japan's FATF 5th Round on-site inspection is August 2028. Evidence of effectiveness cannot be retrospectively created. This 24-month roadmap sets out the preparation phases mid-market institutions must begin now.
Mid-market banks with fintech and crypto counterparty exposure must track five key regulatory changes since 2024. This article maps each change and explains the due diligence obligations they create.
Disconnected KYC and AML systems create three structural compliance failures. This guide explains the integrated six-stage workflow, how it addresses each failure, and the operational ROI of platform consolidation.
Japan's stablecoin legal framework creates specific AML/CTF obligations for electronic payment instrument providers. This guide covers the regulatory structure, stablecoin risk characteristics, and transaction monitoring requirements.
Electronic payment institutions in Japan now face APTCP AML/CTF obligations equivalent to those of banks. This guide covers who is regulated, core obligations, and why manual compliance processes are not viable for digital payment volumes.
The Travel Rule applies to all Japanese financial institutions processing wire transfers — including regional banks. This guide covers the obligation, the most common mid-market gaps, and the required compliance architecture.
Since 2024 Japan's FSA has assessed whether AML/CTF programmes produce outcomes — not whether they exist. This guide covers what effectiveness examiners request and the most common evidence gaps at mid-market institutions.